Literature DB >> 10202928

Antagonism of cytotoxic T-lymphocyte activation by soluble CD8.

A K Sewell1, U C Gerth, D A Price, M A Purbhoo, J M Boulter, G F Gao, J I Bell, R E Phillips, B K Jakobsen.   

Abstract

The CD8 co-receptor is important in the differentiation and selection of class I MHC-restricted T cells during thymic development, and in the activation of mature T lymphocytes in response to antigen. Here we show that soluble CD8alphaalpha receptor, despite an extremely low affinity for MHC, inhibits activation of cytotoxic lymphocytes by obstructing CD3 zeta-chain phosphorylation. We propose a model for this effect that involves interference of productive receptor multimerization at the T-cell surface. These results provide new insights into the mechanism of T-cell activation and evidence that CD8 function is exquisitely sensitive to disruption, an effect that might be exploited by molecular therapeutics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202928     DOI: 10.1038/7398

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  8 in total

1.  Lower concentration of serum soluble CD8 in severe Hashimoto's disease.

Authors:  N Yamamoto; M Watanabe; F Matsuzuka; A Miyauchi; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHC.

Authors:  David K Cole; Pierre J Rizkallah; Malkit Sami; Nikolai M Lissin; Feng Gao; John I Bell; Jonathan M Boulter; Meir Glick; Anne Lise Vuidepot; Bent K Jakobsen; George F Gao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-02-12

Review 3.  The light and dark sides of intestinal intraepithelial lymphocytes.

Authors:  Hilde Cheroutre; Florence Lambolez; Daniel Mucida
Journal:  Nat Rev Immunol       Date:  2011-06-17       Impact factor: 53.106

Review 4.  The molecular determinants of CD8 co-receptor function.

Authors:  David K Cole; Bruno Laugel; Mathew Clement; David A Price; Linda Wooldridge; Andrew K Sewell
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

5.  High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation.

Authors:  Ruth K Moysey; Yi Li; Samantha J Paston; Emma E Baston; Malkit S Sami; Brian J Cameron; Jessie Gavarret; Penio Todorov; Annelise Vuidepot; Steven M Dunn; Nicholas J Pumphrey; Katherine J Adams; Fang Yuan; Rebecca E Dennis; Deborah H Sutton; Andy D Johnson; Joanna E Brewer; Rebecca Ashfield; Nikolai M Lissin; Bent K Jakobsen
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

6.  CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells.

Authors:  Michael N T Souter; Wael Awad; Shihan Li; Troi J Pediongco; Bronwyn S Meehan; Lucy J Meehan; Zehua Tian; Zhe Zhao; Huimeng Wang; Adam Nelson; Jérôme Le Nours; Yogesh Khandokar; T Praveena; Jacinta Wubben; Jie Lin; Lucy C Sullivan; George O Lovrecz; Jeffrey Y W Mak; Ligong Liu; Lyudmila Kostenko; Katherine Kedzierska; Alexandra J Corbett; David P Fairlie; Andrew G Brooks; Nicholas A Gherardin; Adam P Uldrich; Zhenjun Chen; Jamie Rossjohn; Dale I Godfrey; James McCluskey; Daniel G Pellicci; Sidonia B G Eckle
Journal:  J Exp Med       Date:  2022-08-26       Impact factor: 17.579

7.  Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.

Authors:  Nadia Anikeeva; Tatiana Lebedeva; Aaron R Clapp; Ellen R Goldman; Michael L Dustin; Hedi Mattoussi; Yuri Sykulev
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

8.  Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells.

Authors:  Shota Endo; Yuzuru Sakamoto; Eiji Kobayashi; Akira Nakamura; Toshiyuki Takai
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-11       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.